Quick Takeaways
- AH Bio Fund I, L.P. filed SCHEDULE 13G/A for CAMP4 THERAPEUTICS CORPORATION Common Stock, par value $0.0001 per share (CAMP).
- Disclosed ownership: 4.5%.
- Date of event: 30 Sep 2025.
AH Bio Fund I, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for CAMP4 THERAPEUTICS CORPORATION Common Stock, par value $0.0001 per share (CAMP)
- Filing Manager
- AH Bio Fund I, L.P.
- Reporting Manager
- Marc L. Andreessen
- Symbol
- CAMP
- Shares outstanding
- 47,229,756 shares
- Disclosed Ownership
- 2,125,339 shares
- Ownership
- 4.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 18:23:32 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"AH Bio Fund I, L.P. disclosed 4.5% ownership in CAMP4 THERAPEUTICS CORPORATION Common Stock, par value $0.0001 per share (CAMP) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 18:23.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (6)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AH Bio Fund I, L.P. | 3.4% | 1,579,885 | 1,579,885 | 0 | /s/ Phil Hathaway | By AH Equity Partners Bio I, L.L.C., Its General Partner, By Phil Hathaway, Chief Operating Officer (See Note 1) | |
| AH Equity Partners Bio I, L.L.C. | 3.4% | 1,579,885 | 1,579,885 | 0 | /s/ Phil Hathaway | By Phil Hathaway, Chief Operating Officer | |
| AH Bio Fund IV, L.P. | 1.2% | 545,454 | 545,454 | 0 | /s/ Phil Hathaway | By AH Equity Partners Bio IV, L.L.C., Its General Partner, By Phil Hathaway, Chief Operating Officer (See Note 2) | |
| AH Equity Partners Bio IV, L.L.C. | 1.2% | 545,454 | 545,454 | 0 | /s/ Phil Hathaway | By Phil Hathaway, Chief Operating Officer | |
| Marc L. Andreessen | 4.5% | 2,125,339 | 0 | 2,125,339 | /s/ Phil Hathaway | Phil Hathaway, Attorney-in-Fact for Marc L. Andreessen (See Note 3) | |
| Benjamin A. Horowitz | 4.5% | 2,125,339 | 0 | 2,125,339 | /s/ Phil Hathaway | Phil Hathaway, Attorney-in-Fact for Benjamin A. Horowitz (See Note 3) |